JP Stock MarketDetailed Quotes

Takeda Pharmaceutical (4502)

Watchlist
  • 4952.0
  • +39.0+0.79%
20min DelayNot Open Jan 7 15:30 JST
7.88TMarket Cap73.66P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Takeda Pharmaceutical (4502) Revenue Breakdown Overview

By Business/Source

Currency:JPY
2025/FY
Stock NameRevenueRatio
Gastroenterology1.36T29.62%
Plasma Derived Therapies (PDT)1.03T22.54%
Rare Diseases752.82B16.43%
Neuroscience565.82B12.35%
Oncology560.43B12.23%
Other257.39B5.62%
Vaccines55.41B1.21%
View all

By Country/Region

Currency:JPY
2025/FY
Stock NameRevenueRatio
United States (US)2.38T51.94%
Europe and Canada1.06T23.03%
Japan418.46B9.13%
Latin America235.85B5.15%
China191.74B4.19%
Other128.85B2.81%
Asia (excluding Japan & China)99.39B2.17%
Russia/Commonwealth of Independent States (CIS)72.36B1.58%
View all
Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.34%
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +9.84%
4
JD HEALTH
06618
+8.85%
5
ALI HEALTH
00241
+8.61%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +5.97%
Sample Name
Sample Code
 +5.37%
Sample Name
Sample Code
 +2.47%
4
Microsoft
MSFT
+2.09%
5
Alphabet-A
GOOGL
+2.03%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -